Novel role of regulatory T cells in limiting early neutrophil responses in skin

Immunology

Volumn 131, Issue 4, 2010, Pages 583-592

  Richards, Hannah ^a   Williams, Anwen ^b   Jones, Emma ^a   Hindley, James ^a   Godkin, Andrew ^a   Simon, Anna Katharina ^c   Gallimore, Awen ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Neutrophils; Regulatory T cells; Skin; Tumour

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; FAS LIGAND; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DOCUMENTATION; IN VIVO STUDY; INNATE IMMUNITY; INOCULATION; MELANOMA B16; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CXCL1; CHEMOKINE CXCL2; FAS LIGAND PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; IMMUNITY, INNATE; MELANOMA; MICE; NEUTROPHIL INFILTRATION; NEUTROPHILS; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 78149392554     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03333.x     Document Type: Article

References (35)

1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87.
2. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
3. + regulatory T cells maintain immune homeostasis in the skin. J Exp Med 2008; 205:1559-65.
4. Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991; 138:1379-87.
5. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6:353-60.
6. Dannull J, Su Z, Rizzieri D et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 2005; 115:3623-33.
7. Gallimore A, Godkin A. Regulatory T cells and tumour immunity - observations in mice and men. Immunology 2008; 123:157-63.
8. Seino K, Kayagaki N, Okumura K, Yagita H. Antitumor effect of locally produced CD95 ligand. Nat Med 1997; 3:165-70.
9. Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity. Eur J Immunol 2007; 37:758-67.
10. Lowenthal JW, Corthesy P, Tougne C, Lees R, MacDonald HR, Nabholz M. High and low affinity IL-2 receptors: analysis by IL-2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol 1985; 135:3988-94.
11. + regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun 2002; 2:1.
12. Betts G, Twohig J, Van den Broek M, Sierro S, Godkin A, Gallimore A. The impact of regulatory T cells on carcinogen-induced sarcogenesis. Br J Cancer 2007; 96:1849-54.
13. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-41.
14. Simon AK, Gallimore A, Jones E, Sawitzki B, Cerundolo V, Screaton GR. Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. Cancer Cell 2002; 2:315-22.
15. Beckstead JH. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem 1994; 42:1127-34.
16. + Treg and control of Leishmania major infection. J Immunol 2005; 174:5444-55.
17. Clark RA, Kupper TS. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 2007; 109:194-202.
18. Wu MJ, Feldman BF, Zinkl JG, Jain NC. Using red blood cell creatine concentration to evaluate the equine erythropoietic response. Am J Vet Res 1983; 44:1427-32.
19. Anderson RS, Thomson SM, Gutshall LL Jr. Comparative effects of inhaled silica or synthetic graphite dusts on rat alveolar cells. Arch Environ Contam Toxicol 1989; 18:844-9.
20. Gagnon ZE, Newkirk C, Conetta JA, Sama MA, Sisselman S. Teratogenic effect of broad-band electromagnetic field on neonatal mice (Mus musculus). J Environ Sci Health A Tox Hazard Subst Environ Eng 2003; 38:2465-81.
21. Tsuruta D, Mochida K, Hamada T, Ishii M, Wakasa K, Hashimoto S, Takekawa KE. Chemotherapy-induced acral erythema: report of a case and immunohistochemical findings. Clin Exp Dermatol 2000; 25:386-8.
22. Ulich TR, Del Castillo J, Souza L. Kinetics and mechanisms of recombinant human granulocyte colony-stimulating factor-induced neutrophilia. Am J Pathol 1988; 133:630-8.
23. Brach MA, DeVos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992; 80:2920-4.
24. Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 1997; 11:466-78.
25. Wolach B, Van Der Laan LJ, Maianski NA, Tool AT, Van Bruggen R, Roos D, Kuijpers TW. Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro. Exp Hematol 2007; 35:541-50.
26. + T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol 2006; 177:7155-63.
27. Engeman T, Gorbachev AV, Kish DD, Fairchild RL. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol 2004; 76:941-9.
28. James MJ, Belaramani L, Prodromidou K et al. Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood 2003; 102:2173-9.
29. + cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 2004; 173:2942-51.
30. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197:111-9.
31. + T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J Immunol 2004; 172:2286-95.
32. + T cell development for contact hypersensitivity responses. J Leukoc Biol 2005; 78:725-35.
33. + regulatory T cells. J Exp Med 2004; 199:303-13.
34. Rubtsov YP, Rasmussen JP, Chi EY et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28:546-58.
35. De Vries JE. Immunsuppressive and anti-inflammatory properties of interleukin-10. Ann Med 1995; 27:537-41.